Loading...
Market
Commercial availability of at-home saliva test by June 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Major pharmacy chains such as CVS, Walgreens, and official product announcements
Story
New At-Home Saliva Test for Prostate Cancer Analyzing DNA Markers Could Save Thousands of Lives
May 31, 2024, 11:07 PM
Scientists have developed a new at-home saliva test for prostate cancer that promises to revolutionize detection and treatment. The test, which analyzes DNA markers in saliva to determine genetic risk, could save thousands of lives and significantly reduce healthcare costs. This advancement is particularly beneficial for individuals with limited, low-grade, slow-growing prostate cancer who wish to delay surgery or radiation due to concerns about side effects. The test, praised for its affordability and quick results, is expected to enable widespread screening, especially among middle-aged men, potentially turning the tide on prostate cancer. The development has been highlighted by the Daily Express and is based on a landmark study, showcasing the power of domestic diagnostics.
View original story
Similar markets
Below 10% • 25%
10% to 30% • 25%
30% to 50% • 25%
Above 50% • 25%
Yes • 50%
No • 50%
High in urban areas • 25%
High in rural areas • 25%
Uniform across regions • 25%
Low overall adoption • 25%
No competitors respond • 25%
1-2 competitors respond • 25%
3-5 competitors respond • 25%
More than 5 competitors respond • 25%
CVS • 33%
Walgreens • 33%
Walmart • 34%